Appointments

866.320.4573

Submit a Form

Questions

800.223.2273

Submit a Form

Expand Content

Samuel Szomstein, MD

877.463.2010

Samuel Szomstein, MD

Appointed: 2002

Samuel Szomstein, MD
Department: Bariatric and Metabolic Institute (BMI)
Location: Florida, Weston
Mail Code WESTON
2950 Cleveland Clinic Boulevard
Weston, FL 33331
WorkAppointment:877.463.2010
DeskDesk:954.659.5249
WorkFax:954.659.5256
Samuel Szomstein, MD
Department: General Surgery Florida
Location: Florida, Weston
Mail Code WESTON
2950 Cleveland Clinic Boulevard
Weston, FL 33331
WorkAppointment:877.463.2010
DeskDesk:954.659.5249
WorkFax:954.659.5256
Surgeon:
Yes
Treats:
Adults Only

Biographical Sketch

Under the Leadership of Raul Rosenthal, MD and Samuel Szomstein, MD, the Section of Minimally Invasive Surgery (SMIS) and The Bariatric and Metabolic Institute (BMI) at Cleveland Clinic Florida has over 17 full time staff members exclusively dedicated to the care and well being of surgical and morbidly obese patients.

Our staff is multilingual and diverse in ethnicity. Languages spoken fluently are English, Spanish and German. The surgeons operate exclusively at Cleveland Clinic Florida.

This multidisciplinary approach as well as their experience and outcomes are the reason why The Section of Minimally Invasive Surgery and The Bariatric and Metabolic Institute have been named Center of Excellence by the Surgical Review Corporation and the American Society for Metabolic and Bariatric Surgeons, The American College of Surgeons and The Fellowship Council. Close to 1000 General Surgery and Bariatric procedures are performed on a yearly basis by our team. Over 4,000 Bariatric Surgeries have been performed to date at the BMI making it the largest bariatric program in the state of Florida.

Medical research and Education are also cornerstones of the SMIS and BMI.

Over 400 publications including scientific papers, posters, abstracts, book chapters, educational videos and textbooks have been published by the SMIS and BMI.

Under the guidance of Dr. Rosenthal and Dr. Szomstein the Section of Minimally Invasive Surgery and the Bariatric and Metabolic Institute have one of the largest training programs in the USA, mentoring four clinical and four research fellows on a yearly basis. Over the last 10 years, more than 50 fellows trained at our institution.

Fellows that come to Cleveland Clinic Florida from around the globe are involved in both national and international research in the field of obesity, minimally invasive and endoscopic surgical techniques. Both, Dr. Rosenthal and Dr. Szomstein are invited speakers to national and international conferences and have conducted over 11 FDA trials.

Professional Highlights

  • Center and Surgeon of Excellence of The American Society of Metabolic and Bariatric Surgery (ASMBS)
  • Center and Surgeon of Excellence of The American College of Surgeons (ACS)
  • Full accreditation by The Fellowship Council in Minimally Invasive and Bariatric Surgery

Education & Fellowships

Fellowship - Cleveland Clinic Florida
Laparoscopic Surgery (minimally invasive surgery)
Weston, FL USA
2002
Residency - New York Hospital Medical Center of Queens
Surgery
Flushing, NY USA
2001
Residency - Long Island Jewish Medical Center
Surgery
New Hyde Park, NY USA
1997
Internship - Long Island Jewish Medical Center
Surgery
New Hyde Park, NY USA
1996
Medical School - Universidad Central de Venezuela
Caracas Venezuela
1993

Certifications

  • Surgery

Specialty Interests

Abdominal wall hernia, bariatric surgery, flexible endoscopy, metabolic surgery, minimally invasive surgery

Awards & Honors

  • Physician of the Year Award, by Cleveland Clinic Hospital in the category of Service. March 2004.
  • Physician of the Quarter Award, by Cleveland Clinic Hospital in the category of Growth. 3rd Quarter 2003.
  • Physician's Recognition Award, by The American Medical Association, March 2003.
  • Certificate of Excellence, by the Cleveland Clinic Florida Operating Room Operations Committee, for outstanding performance and exceptional commitment to the efficiency of the operating room. April 2007.
  • Innovator Award, by Cleveland Clinic for commitment to bring new technology to patients worldwide.(Rectal desimpactor device) June 2007.
  • Innovator Award, by Cleveland Clinic for commitment to bring new technology to patients worldwide.(Bariatric orogastric anastomotic suturing tube and Esophageal double suction isolator tube) June 2006.
  • "America's Top Surgeons," by the Consumers Research Council of America. 2004-2005 edition. Washington, DC.
  • "America's Top Surgeons," by the Consumers Research Council of America. 2005-2006 edition. Washington, DC.
  • Leadership Award, voted by fellow residents and attendings of The New York Hospital of Queens for the greatest contribution to the quality and life of the residency program, July 2001.

Innovations & Patents

  • Innovator Award, by Cleveland Clinic for commitment to bring new technology to patients worldwide. (Rectal desimpactor device) June 2007.
  • Innovator Award, by Cleveland Clinic for commitment to bring new technology to patients worldwide. (Bariatric orogastric anastomotic suturing tube and Esophageal double suction isolator tube) June 2006.

Memberships

  • Fellow, American College of Surgeons
  • Council Member, South Florida Chapter of the American College of Surgeons
  • Member, American Society of Metabolic and Bariatric Surgery (ASMBS)
  • Member, American Hernia Society
  • Member, Society of American Gastrointestinal Endoscopic Surgeons (SAGES)
  • Member, The Society for Surgery of the Alimentary Tract (SSAT)
  • Member, American Obesity Association

Treatment & Services

  • Complex Abdominal Hernia Repair
  • Endoscopy
  • Gastric Bypass Surgery with Focus on Reflux Disease
  • Hernia Surgery
  • Laparoscopic Cholecystectomy
  • Laparoscopic Hernia Surgery
  • Laparoscopic Incisional Hernia Repair
  • Laparoscopic Inguinal Hernia Repair
  • Laparoscopic Liver Surgery
  • Laparoscopic Surgery
  • Pancreatic Surgery
  • Revisional Gastric Bypass Surgery

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 10/9/2014, Dr. Szomstein has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
  • Hebrew
  • Spanish